Authors:
KRIBBEN A
BREMER C
FRITSCHKA E
KOEPPEN S
AHRENS O
PHILIPP T
Citation: A. Kribben et al., AMBULATORY INFUSION OF NORADRENALINE FOR LONG-TERM TREATMENT OF SHY-DRAGER-SYNDROME, Kidney & blood pressure research, 21(1), 1998, pp. 70-73
Citation: Es. Strobel et E. Fritschka, CASE-REPORT AND REVIEW OF THE LITERATURE - FATAL PULMONARY COMPLICATION IN ANKYLOSING-SPONDYLITIS, Clinical rheumatology, 16(6), 1997, pp. 617-622
Authors:
THURMANN PA
HARDER S
WOLTER K
MUNCK AC
FRITSCHKA E
Citation: Pa. Thurmann et al., PHARMACOKINETICS OF THE PDGF-ANTAGONIST TRAPIDIL IN PATIENTS WITH ANDWITHOUT RENAL IMPAIRMENT, Clinical nephrology, 47(2), 1997, pp. 99-105
Authors:
FRITSCHKA E
WIEWER J
STOSSER R
POOTH R
STROBEL ES
LAMMLEIN M
KIRSTEN R
PHILIPP T
Citation: E. Fritschka et al., PHARMACODYNAMICS OF PIRETANIDE, RAMIPRIL, AND THEIR COMBINATION IN VOLUNTEERS WITH NORMAL KIDNEY-FUNCTION, Nieren- und Hochdruckkrankheiten, 26(5), 1997, pp. 185-191
Citation: A. Kribben et al., AMBULATORY INFUSION OF NORADRENALINE FOR LONG-TERM TREATMENT OF SHY-DRAGER SYNDROME, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1508-1508
Authors:
CHEN H
BECKER G
WAGNER K
PHILIPP T
WAMBACH G
FRITSCHKA E
Citation: H. Chen et al., FK-506 REDUCES THE ENDOTHELIUM-DEPENDENT RELAXATION OF RAT MESENTERIC-ARTERIES LESS-THAN CYCLOSPORINE, Nieren- und Hochdruckkrankheiten, 24(6), 1995, pp. 295-298
Authors:
HELLINGER A
WOLTER K
MARGGRAF G
PENTZ R
FRITSCHKA E
Citation: A. Hellinger et al., ELIMINATION OF AMRINONE DURING CONTINUOUS VENOVENOUS HEMOFILTRATION AFTER CARDIAC-SURGERY, European Journal of Clinical Pharmacology, 48(1), 1995, pp. 57-59
Citation: T. Rudy et al., LONG-TERM FOLLOW-UP OF PLASMA ENDOTHELIN AND INTERLEUKIN-2 RECEPTOR LEVELS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION IN HUMANS, Langenbecks Archiv fur Chirurgie, 380(3), 1995, pp. 189-193
Citation: K. Wolter et al., TEICOPLANIN PHARMACOKINETICS AND DOSAGE RECOMMENDATIONS IN CHRONIC-HEMODIALYSIS PATIENTS AND IN PATIENTS UNDERGOING CONTINUOUS VENOVENOUS HEMODIALYSIS, Clinical nephrology, 42(6), 1994, pp. 389-397
Citation: E. Fritschka et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF QUINAPRILAT IN HYPERTENSIVE DIALYSIS PATIENTS, Nieren- und Hochdruckkrankheiten, 23(5), 1994, pp. 225-227
Authors:
WOLTER K
MARGGRAF G
DERMOUMI H
FRITSCHKA E
Citation: K. Wolter et al., ELIMINATION OF FLUCONAZOLE DURING CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD) IN A SINGLE PATIENT, European Journal of Clinical Pharmacology, 47(3), 1994, pp. 291-292
Authors:
WOLTER K
MARGGRAF G
DERMOUMI H
FRITSCHKA E
Citation: K. Wolter et al., ELIMINATION OF FLUCONAZOLE DURING CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD) IN A SINGLE PATIENT, European Journal of Clinical Pharmacology, 47(3), 1994, pp. 291-292
Citation: K. Wolter et al., INTERACTION BETWEEN FK-506 AND CLARITHROMYCIN IN A RENAL-TRANSPLANT PATIENT, European Journal of Clinical Pharmacology, 47(2), 1994, pp. 207-208
Citation: K. Wolter et al., PHARMACOKINETICS AND DOSAGE RECOMMENDATIONS OF TEICOPLANIN IN PATIENTS TREATED BY CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD), European Journal of Clinical Pharmacology, 46(2), 1994, pp. 179-180
Authors:
RUDY T
HARTWIG T
FRITSCHKA E
ERHARD J
EIGLER FW
Citation: T. Rudy et al., MONITORING OF PLASMA ENDOTHELIN IN RELATION TO DOPPLER SIGNAL IN HUMAN LIVER-TRANSPLANTATION, Transplantation proceedings, 25(4), 1993, pp. 2658-2661